Adaptive Biotechnologies Corp Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Adaptive Biotechnologies Corp quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Adaptive Biotechnologies Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 147M shares, a 2.09% increase year-over-year.
  • Adaptive Biotechnologies Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 144M shares, a 1.31% increase from 2022.
  • Adaptive Biotechnologies Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 143M shares, a 1.54% increase from 2021.
  • Adaptive Biotechnologies Corp annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 140M shares, a 6.96% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 147M +3.02M +2.09% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 146M +2.28M +1.59% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 144M +1.87M +1.31% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 145M +1.78M +1.24% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 144M +2.03M +1.43% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 144M +1.81M +1.28% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 143M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 143M +2.1M +1.49% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 142M +2M +1.43% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 142M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q3 2021 141M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 140M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.